Navigation Links
A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits
Date:7/14/2009

VIENNA, July 15 /PRNewswire-USNewswire/ -- New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090529/ICADLOGO )

Scientists also reported on how clinicians view and treat mild cognitive impairment (MCI), a research category used to define the state between normal aging and Alzheimer's, that is now being used widely in clinical practice.

"There are now more than 5 million people living with Alzheimer's disease in the United States. The cost of caring for people who now have Alzheimer's, and those who will get it in the next few years, will bankrupt the healthcare system and devastate Medicare and Medicaid," said Ralph Nixon, PhD, MD, vice chair of the Alzheimer's Association Medical & Scientific Advisory Council.

"But, as these studies and many hundreds more reported at ICAD 2009 show, there is hope. There are currently dozens of drugs in Phase II and III clinical trials for Alzheimer's. This, combined with advancements in diagnostic tools, has the potential to change the landscape of Alzheimer's in our lifetime. How fast we get there depends completely on the investment in research. We need more government and private dollars for Alzheimer's research now to capitalize on the progress we've made in the last decade," Nixon added.

Surprisingly, Dimebolin Increases Brain Beta Amyloid in Alzheimer's Mouse Models

R
'/>"/>

SOURCE Alzheimer's Association
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Manic phase of bipolar disorder benefits from breast cancer medication
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...cialist manufacturers who use medical load cells a...of dollars by bringing in technology partner Flint... of pro-active medical manufacturers are calling i...f their projects, ensuring that progress will not ...entially outdated technology. , ...
(Date:11/26/2009)...g tetrathiomolybdate (TM) has been shown in studie...se, a disease caused by an overload of copper, and...ery little, however, is known about how the drug w...y Northwestern University researchers now has prov...ucture of TM bound to copper-loaded metallochapero...
(Date:11/26/2009)...earch Triangle Dental (RTDental), a leading dental...nnounced the expansion of its services to include ...g Macmillan. , Durham,... to announce that Dr. Doug Macmillan, an experienc...tional advanced training seminar. RTDental’...
(Date:11/25/2009)....25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,I...hosttwoinvestoreventsinDecember: ,, ASHBriefi... ,, Principalinvestigatorswilldiscussdatapres...ractorymultiplemyeloma,asfeaturedatthe51stAmerican...inNewOrleans,LA.Theteleconferencewillbeginat9:00a....
(Date:11/25/2009)...ewswire-USNewswire/--TheBlackAIDSInstituterecently...adershipfor2010. ,, ThenewBoardMembersareahighl...y,law,finance,governmenthealthprograms,editorial,a...iderangeofpersonalbackgroundsincludingbothheterose...lves,andrepresentingmultipleagegroups. ,, (Phot...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... of Switzerland finds children who are exposed to ... also have asthma or allergies. Researchers had pa...ires// regarding asthma and hay fever. They also t...r levels of endotoxin, a component of the cell wal...
...hen it comes to health issues. In California, trav...o smoke for residents. Environmental tobacco smoke...nge of adverse health effects - from exacerbation ...sity of California have studied a group of 200 peo...
... with mood disorders who have attempted suicide ar...ll. The link is especially strong among those who ...suffer from mood disorders themselves. Resear...people at especially high risk. Researchers from t...
...tion may unclog a mechanical heart pump, reconditi...researcher from University Hospital in Germany,// ...ous problem for heart failure patients who receive...pumping ability of a heart that can't dynamically ...
...preventable cause of death. Turning off the televi...w study finds the more an adolescent watches telev...//The risk of disease increases the earlier in lif...ising on television, smoking is still widespread o...
...th a higher dose of radiotherapy, with weekends o...involves a daily dose of radiotherapy five days a ...n found from a more intensive programme known as C... computer models, they suggested that a higher dos...
Other Medicine News:
(Date:11/27/2009)...PRNewswire/--ACUOTECHNOLOGIES,developersofhigh-per...ontoolsandservices,ispleasedtoannouncethattheUnite...pplicationforan"AssetCommunicationFormatwithinaCom....patenttoitsportfolioofintellectualproperty.Ingene...,stechnologyanduseofassetmetainformationtocontrolr...
(Date:11/25/2009)...Newswire-FirstCall/--HeskaCorporation(HSKA);("Hesk...altyproductstotheveterinaryindustry,announcedtoday...plyofbloodgasproductsandaffiliatedconsumablesforth....com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "Hesk...dofadvancedpoint-of-carediagnostics,"commentedMich...
(Date:11/25/2009)...ire/--BioTrendsResearchGroup,Inc.releasedWave1ofit...amulti-phasesyndicatedmarketresearchprojecttrackin...ductlaunchthroughthefirstsixmonthsofavailability.E...rom75uniqueDermatologistsandqualitativeinformation...ra,obstaclestouse,typicalpatienttypes,productperce...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 1DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 2DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 3Government of Canada announces funding for research on the H1N1 flu virus 8732 1Government of Canada announces funding for research on the H1N1 flu virus 8732 2Ludwig Institute of Cancer Research Ltd Brussels Branch Issues Statement Concerning Prospect Therapeutics Incs GCS 100 Molecule 48071 1Ludwig Institute of Cancer Research Ltd Brussels Branch Issues Statement Concerning Prospect Therapeutics Incs GCS 100 Molecule 48071 2
...x S.A.,(Eurolist: COX) today announced that Merck ... planned clinical studies, in mild to moderate,hyp...tive agreement to,develop new nitric oxide-donatin...technology. Three drug candidates have now been se... of which two have completed initial,dose ranging ...
...n Prevention Business, DUBLIN, Ohio, May 12 Card...vices that improve the safety and,productivity of ...acquisition of assets of privately held Enturia, I...ucts sold under the ChloraPrep(R) brand name., Ch... hospitals and,surgery centers as a patient preope...
Other Medicine Technology:NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3Cardinal Health Completes Enturia Acquisition 2
Gamma GT (GLUPA)
Creatine Kinase (CK-NAC) SZASZ
Cholesterol (CHOD-PAP) (DIMENSION)
Cholesterol (Liquid)
Medicine Products: